Corcept Therapeutics | CORT - Ativos





Ativos Alterar Data
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Canopy Growth CAD 1.12B 12.54M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Eli Lilly USD 116.58B 4.1B 2026-03
J&J USD 201.06B 167M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Merck USD 128.68B 8.18B 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 122.03B 3.5B 2026-06
Novartis USD 118.53B 7.58B 2026-03
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.21B 56.38M 2026-03
Pfizer USD 207.62B 542M 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
TG Therapeutics USD 1.53B 465.58M 2026-03